Psilocybin will receive Breakthrough Therapy Designation for cocaine use disorder within 12 months based on today's RCT data.

Randomized cocaine use disorder RCT is exactly the kind of controlled evidence that triggers BTD consideration. No approved pharmacotherapy exists for cocaine — unmet need threshold is already met.